Expert Review of Pharmacoeconomics & Outcomes Research

Article	Citations
Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications	48
Distinguishing features in the assessment of mHealth apps	38
Real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic	37
Health-related quality of life in patients with chronic kidney disease	27
Tools to assess the quality of life in patients with Parkinson’s disease: a systematic review	27
First-line atezolizumab plus chemotherapy in advanced non-squamous non-small cell lung cancer: a cost-effectiveness analysis from China	26
Will the Markov model and partitioned survival model lead to different results? A review of recent economic evidence of cancer treatments	23
Evaluation instruments for executive functions in children and adolescents: a systematic review	20
Outcome measures for physical fatigue in individuals with multiple sclerosis: a systematic review	18
A comparison of measurement properties between UK SF-6D and English EQ-5D-5L and Thai EQ-5D-5L value sets in general Thai population	17
Micro-costing diagnostics in oncology: from single-gene testing to whole- genome sequencing	17
Cost-effectiveness of using a 20-valent pneumococcal conjugate vaccine to directly protect adults in England at elevated risk of pneumococcal disease	16
Prevalence of chronic respiratory morbidity, length of stay, inpatient readmissions, and costs among extremely preterm infants with bronchopulmonary dysplasia	16
Cost-effectiveness of adding durvalumab to first-line chemotherapy for extensive-stage small-cell lung cancer in China	15
Resource utilization, work productivity and costs in patients with hidradenitis suppurativa: a cost-of-illness study	15
Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis	14
Gap analysis in manufacturing, innovation and marketing of medical devices in the Asia-Pacific region	13
A review of quality-of-life in elderly osteoarthritis	12
Estimating the economic consequences of substance use and substance use disorders	12
Artificial intelligence in outcomes research: a systematic scoping review	12
Productivity loss/gain in cost-effectiveness analyses for vaccines: a systematic review	12
The cost-effectiveness of once-weekly semaglutide compared with other GLP-1 receptor agonists in type 2 Diabetes: a systematic literature review	11
Cost-effectiveness of pertuzumab and trastuzumab biosimilar combination therapy as initial treatment for HER2-positive metastatic breast cancer in Singapore	11
Cost-utility analysis and budget impact of benralizumab as add-on therapy to standard care for severe eosinophilic asthma in Colombia	11
Economic burden associated with stroke in India: insights from national sample survey 2017-18	10

Cost of illness in multiple sclerosis by disease characteristics – A review of reviews	10
Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspe	10
The pharmacoeconomic impact of follitropin alpha biosimilars in IVF therapy in Europe: a report of the literature	10
Cannabis use among Canadian adults with cancer (2007–2016): results from a national survey	9
All-cause community acquired pneumonia cost by age and risk in real-world conditions of care in Spain	9
Cost-utility of dapagliflozin plus standard treatment compared to standard treatment for the management of heart failure with reduced ejection fraction in Colombia	9
Design of a health-economic Markov model to assess cost-effectiveness and budget impact of the prevention and treatment of depressive disorder	9
An update on the economic burden of type 2 diabetes mellitus in China	9
Not cost-effective at zero price: valuing and paying for combination therapies in cancer	9
Costs of medication use among patients with juvenile idiopathic arthritis in the Dutch healthcare system	9
Adapting health technology assessment for drugs, medical devices, and health programs: Methodological considerations from the Indian experience	9
Cost-effectiveness analysis of donafenib versus lenvatinib for first-line treatment of unresectable or metastatic hepatocellular carcinoma	9
Evidence of long-term real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic	8
Cost-utility analysis of dupilumab add on therapy versus standard therapy in adolescents and adults for severe asthma in Colombia	8
Economic burden of comorbidities among COPD Patients hospitalized for acute exacerbations: an analysis of a commercially insured population	8
Understanding long-listed pharmaceutical products without competition in South Korea: policy implications in managing generic entrants and pharmaceutical expenditures	8
Cost-effectiveness of osimertinib versus standard EGFR-TKI as first-line treatment for locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer in Australia	8
Acceptability and willingness to pay for a hypothetical vaccine against SARS CoV-2 by the Brazilian consumer: a cross-sectional study and the implications	8
Exploring the consistency of the SF-6Dv2 in a breast cancer population	8
Can we achieve affordable cancer medicine prices? Developing a pathway for change	8
Impact on hospitalizations of long-term versus short-term therapy with sodium zirconium cyclosilicate during routine outpatient care of patients with hyperkalemia: the recognize I study	7
Cost-effectiveness analysis of olaparib and niraparib as maintenance therapy for women with recurrent platinum-sensitive ovarian cancer	7
Cost-effectiveness of trifluridine/tipiracil as a third-line treatment of metastatic gastric cancer, including adenocarcinoma of the gastrohesophageal junction, among patients previously treated in Gr	7
In-hospital economic burden of anastomotic leakage after colorectal anastomosis surgery: a real-world cost analysis in Italy	7
Assessment of the properties of the EQ-5D-5L in patients with type 2 diabetes mellitus: a systematic review and meta-analysis	7
Cost-effectiveness of olaparib maintenance therapy when used with and without restriction by BRCA1/2 mutation status for platinum-sensitive relapsed ovarian cancer	7
Durvalumab consolidation therapy in patients with stage III non-small cell lung cancer after concurrent chemoradiation: a China-based cost-effectiveness analysis	7
Can artificial intelligence separate the wheat from the chaff in systematic reviews of health economic articles?	7
Cost-effectiveness analyses of targeted therapy and immunotherapy for advanced non-small cell lung cancer in the United States: a systematic review	7
Burden of illness the first year after diagnosed bladder dysfunction among people with spinal cord injury or multiple sclerosis – a Danish register study	7
The Economic and societal burden of multiple sclerosis on lebanese society: a cost-of-illness and quality of life study protocol	7
Pembrolizumab plus lenvatinib or axitinib compared to nivolumab plus ipilimumab or cabozantinib in advanced renal cell carcinoma: a number needed to treat analysis	6
Budget impact analysis of subcutaneous trastuzumab compared to intravenous trastuzumab in Saudi HER2-positive breast cancer patients	6
Cost-effectiveness analyses comparing cemented, cementless, hybrid and reverse hybrid fixation in total hip arthroplasty: a systematic overview and critical appraisal of the current evidence	6
The economic value of knowing BRCA status: universal BRCA testing for breast cancer prevention	6
Considering potential solutions for limitations and challenges in the health economic evaluation of gene therapies	6
Systematic reviews of machine learning in healthcare: a literature review	6
The impact of changing the funding model for genetic diagnostics and improved access to personalized medicine in oncology	6
Trends in the pricing and reimbursement of new anticancer drugs in South Korea: an analysis of listed anticancer drugs during the past three years	6
Pharmacoeconomics of obesity in China: a scoping review	6
Cost-effectiveness analysis of tofacitinib compared with adalimumab and etanercept in the treatment of severe active rheumatoid arthritis; Iranian experience	6
Health and economic impact of the correct diagnosis of transthyretin cardiac amyloidosis in Spain	6
Healthcare resource utilization in patients with newly diagnosed atrial fibrillation in the United States	5
A systematic review and meta-regression of studies eliciting willingness-to-pay per quality-adjusted life year in the general population	5
Direct medical costs of breast cancer in Jordan: cost drivers and predictors	5
Economic evaluation of toripalimab plus chemotherapy compared with chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma in China	5
Assessing the pricing and benefits of oncology products: an update	5
Summary of the 2020 AHRQ research meeting on ‘advancing methods of implementing and evaluating patient experience improvement using consumer assessment of healthcare providers and systems (CAHPS®) sur	5
Tackling reimbursement challenges to fair access to medicines – introduction to the topic	5
A systematic review of cost-effectiveness analyses of continuous versus intermittent renal replacement therapy in acute kidney injury	5

Prevalence and direct costs of potentially inappropriate prescriptions in France: a population-based study	5
Cost-utility analysis of ceftazidime-avibactam versus colistin-meropenem in the treatment of infections due to Carbapenem-resistant Klebsiella pneumoniae in Colombia	5
Assessing the value contribution of bimekizumab for the treatment of moderate-to-severe psoriasis using a multidisciplinary reflective multi-criteria decision analysis	5
Estimating the annual economic burden for the management of patients with transthyretin amyloid polyneuropathy in Spain	5
Cost-effectiveness of treatments for HER2-positive metastatic breast cancer and associated metastases: an overview of systematic reviews	4
How can societal culture and values influence health and rehabilitation outcomes?	4
Cost-effectiveness of dapagliflozin compared to DPP-4 inhibitors as combination therapy with metformin in the treatment of type 2 diabetes mellitus without established cardiovascular disease in Colomb	4
Cost-effectiveness of camrelizumab plus chemotherapy versus chemotherapy alone as first-line therapy in advanced or metastatic esophageal squamous cell carcinoma	4
A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19.	4
The costs of treatment resistant depression: evidence from a survey among Italian patients	4
Value elements and methods of value-based pricing for drugs in Japan: a systematic review	4
Economic evaluation of ivabradine in treatment of patients with heart failure: a systematic review	4
Is it a chimera? A systematic review of the economic evaluations of CAR-T cell therapy - an update	4
Burden of disease and costs of infections associated with cardiac implantable electronic devices	4
A review of caregiver costs included in cost-of-illness studies	4
Identification of risk factors of 30-day readmission and 180-day in-hospital mortality, and its corresponding relative importance in patients with Ischemic heart disease: a machine learning approach	4
Early technology assessment of using whole genome sequencing in personalized oncology	4
Incorporating health inequality impact into economic evaluation in low- and middle-income countries: a systematic review	4
Budget impact analysis of medicines: estimated values versus real-world evidence and the implications	4
Preference of young adults for COVID-19 vaccination in the United Kingdom: a discrete choice experiment	4
The economic burden of biologic disease-modifying antirheumatic drugs in rheumatoid arthritis patients in the United States	4
Cost-related nonadherence for prescription medications: a cross-sectional study in Jordan	4
Assessment of women’s treatment preferences for vasomotor symptoms due to menopause	4
Budget impact of introducing subcutaneous vedolizumab as a maintenance therapy in biologic-naïve and biologic-experienced patients with ulcerative colitis in France	4
Predicting key drivers for health care expenditure growth in the Middle East region: a Grossman-PLS modeling approach	4
A comparison of six approaches for measuring utility values among patients with locally advanced cervical cancer	4
Bringing the patient’s perspectives forward in drug development and health-care evaluation	4
The impact of fibrodysplasia ossificans progressiva (FOP) on patients and their family members: results from an international burden of illness survey	4
Assessing the impact of kidney cancer-related premature mortality and productivity loss in Greece and Portugal	4
Recommendations for economic evaluations of cell and gene therapies: a systematic literature review with critical appraisal	4
Impact of single-pill combinations versus free-equivalent combinations on adherence and persistence in patients with hypertension and dyslipidemia: a systematic literature review and meta-analysis	4
Cost-effectiveness of acalabrutinib regimens in treatment-naïve chronic lymphocytic leukemia in the United States	3
The substantial costs to society associated with obesity – a Danish register-based study based on 2002-2018 data	3
How do hospital characteristics and ties relate to the uptake of second-generation biosimilars? A longitudinal analysis of Portuguese NHS hospitals, 2015–2021	3
Cost-benefit analysis of hepatic resection, radiofrequency ablation and liver transplantation in small hepatocellular carcinoma	3
Cost-effectiveness of pharmacist-led care versus usual care in type 2 diabetic Jordanians: a Markov modeling of cardiovascular diseases prevention	3
Cost-utility analysis of stereotactic body radiotherapy plus cetuximab in previously irradiated recurrent squamous cell carcinoma of the head and neck	3
Patient associations and clinical oncology research: how much does a patient’s voice really matter?	3
Economic evaluation of reproductive carrier screening for recessive genetic conditions: a systematic review	3
The societal costs of multiple sclerosis in Lebanon: a cross-sectional study	3
Patient preferences for elagolix and leuprolide for treating endometriosis-related pain in the United States	3
A landscape analysis and discussion of value of gene therapies for sickle cell disease	3
The impact of statistical properties of incremental monetary net benefit and incremental cost-effectiveness ratio on health economic modeling choices	3
The impact of universal health coverage and COVID-19 pandemic on out-of-pocket expenses in Thailand: an analysis of household survey from 1994 to 2021	3
A pre-vaccine analysis using the Health Belief Model to explain parents’ willingness to vaccinate (WTV) their children in the United States: implications for vaccination programs	3
Moving beyond the stage: how characteristics at diagnosis dictate treatment and treatment-related quality of life year losses for women with early stage invasive breast cancer	3
Cost-effectiveness analysis of the first‐line EGFR‐TKIs in patients with advanced EGFR-mutated non-small-cell lung cancer	3
Design and testing of a health economic Markov model for treatment of anorexia nervosa	3
Capturing the holistic value of biosimilars in Europe – part 1: a historical perspective	3
Value-based health care in Western countries: a scoping review on the implementation of patient-reported-outcomes sets for hospital-based interventions	3
Canadian French translation and linguistic validation of the health-related quality of life utility measure for pre-school children	3
Cost-effectiveness of nivolumab in advanced melanoma: a drug review	3
Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care	3
The affordability of adding a direct-acting oral anticoagulant to the national list of essential medicine for patients with non-valvular atrial fibrillation in Thailand: a budget impact analysis	3
Cost-utility analysis of the anti-TNF therapy for rheumatoid arthritis in a real-world based model	3
Multicriteria decision analysis in health care decision in oncology: a systematic review	3
Contemporary outcomes studies to identify and mitigate the risk in patients with premature cardiovascular disease	3
Estimation of the economic burden of atrial fibrillation-related stroke in Greece	3
Cost-effectiveness of daratumumab in combination with lenalidomide and dexamethasone for relapsed and/or refractory multiple myeloma	3
Budget impact and pharmacy costs with targeted use of oliceridine for postsurgical pain in patients at high risk of opioid-related adverse events	3
A systematic review of cost-effectiveness analyses across the acute kidney injury landscape	3
Cost-effectiveness analysis of trastuzumab for early breast cancer in Brazil	3
Comparative cost-effectiveness of radiotherapy among older women with hormone receptor positive early-stage breast cancer	3
Determination of the economically justifiable price of cenobamate in the treatment of focal-onset seizures in adult patients with drug-resistant epilepsy in Spain	3
Tenecteplase in managing acute ischemic stroke: a long-term cost–utility analysis in Iran	3
Pharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review	3
Economic evaluation of adalimumab versus etanercept for psoriatic arthritis in a Brazilian real-world model	2
Chronic inflammatory demyelinating polyneuropathy in Spain: a retrospective analysis of hospital incidence and medical costs	2
Evaluating discrete choice experiment willingness to pay [DCE-WTP] analysis and relative social willingness to pay [RS-WTP] analysis in a health technology assessment of a treatment for an ultra-rare	2
Policy solutions for medication non-adherence: what can governments do?	2
Cost-effectiveness of childhood influenza vaccination in Europe: results from a systematic review	2
Cost-utility analysis of sacituzumab govitecan versus chemotherapy for the treatment of metastatic triple-negative breast cancer in Singapore	2
Social and economic burden of breast cancer in the North East region of Bulgaria	2
Review of economic modeling evidence from NICE appraisals of rare disease treatments for spinal muscular atrophy	2
Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in Canada	2
Medicaid best price reforms to enable innovative payment models for cell and gene therapies	2
Budgetary impact analysis of alteplase - recombinant tissue plasminogen activator (rtPA) - as a thrombolytic treatment for acute ischemic stroke in Colombia	2
Mapping the FACT-G to EQ-5D-3L utility index in cancer with the Chinese values set	2
Measuring valued output in primary care: challenges and reconciliation	2
Assessment of Quality of Life 8-Dimension (AQoL-8D): translation, validation, and application in two Dutch trials in patients with epilepsy and schizophrenia	2

Overview and quality assessment of health economic evaluations for homeopathic therapy: an updated systematic review	2
Cost-utility and budget impact analysis of CPAP therapy compared to no treatment in the management of moderate to severe obstructive sleep apnea in Colombia from a third-party payer perspective	2
Revival? Prospects for a return to comprehensive and coordinated health technology assessment in America	2
Analysis of patients’ access to reimbursed biotechnological medicines for multiple sclerosis in Bulgaria and Greece	2
Economic and humanistic burden in kidney transplant rejection: a literature review	2
Burden of disease of chronic pain in Colombia	2
Hospital care of endometriosis in Spain: a retrospective multicenter analysis of patient characteristics and costs	2
Evaluation of the economic benefits, administration times, and patient preferences associated with the use of biotechnological drugs administered subcutaneously and intravenously in patients with canc	2
Burden of illness among intermittent catheter users with non-neurogenic urinary retention in Denmark	2
Association of congestive heart failure with hospital outcomes among renal cancer patients in the United States: analysis of nationwide inpatient sample	2
Cost-utility model of brivaracetam in the adjunctive treatment of patients with epilepsy in Spain	2
Comparing multi-attribute utility instruments: CP-6D, a Cerebral palsy specific instrument, vs AQoL-4D	2
The impact of bone turnover marker on medication adherence and the health economics-related consequences	2
Hyperbaric oxygen therapy as an adjunct to the standard wound care for the treatment of diabetic foot ulcers in Indian patients: a cost utility analysis	2
International comparability of reference unit costs of education services: when harmonizing methodology is not enough (PECUNIA project)	2
Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain	2
Incorporating patients’ preferences in the value assessment of disease-modifying therapies for multiple sclerosis: a narrative review	2
Prescription analysis and cost of antidepressant drugs in major depressive disorder outpatients at the tertiary care hospital of Pakistan: a prospective approach	2
Health economic evaluation of different treatment strategies for peripheral entrapment mononeuropathies: a systematic review	2
Cost-effectiveness analysis of nivolumab-chemotherapy as first-line therapy for locally advanced/metastatic gastric cancer: a United States payer perspective	2
Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant	2
Interface policies bridging outpatient and hospital sectors in Europe: can cross-sectorial collaboration in reimbursement and procurement improve access to affordable medicines?	2
A systematic review of economic evaluations of vaccines in Middle East and North Africa countries: is existing evidence good enough to support policy decision-making?	2
Accounting for inflation within NICE cost-effectiveness thresholds	2
Economic evaluation of interventions to improve medication adherence among patients with chronic diseases: an overview of systematic reviews	2
Health-related quality of life in women with autoimmune thyroid disease during pregnancy and postpartum: systematic review including 321,850 pregnancies	2
Story completion (SC) – an epistemological approach to the interpretation of patient-reported outcomes?	2
Evaluating high-cost technologies – no need to throw the baby out with the bathwater	2
Short-term costs in patients with chronic kidney disease treated with dapagliflozin: a retrospective cohort study	2
Precision medicine in Thoracic Oncology: understanding disparities to tackle inequities in access	2
Performance-based risk-sharing agreements in renal care: current experience and future prospects	2
Access and pricing of medicines for patients with rare diseases in the European Union: an industry perspective	2
The challenge of value-based pricing in combination therapy: the case of trastuzumab and pertuzumab in HER2+ metastatic breast cancer	2
Conducting economic evaluation based on basket clinical trial in the area of precision medicine	2
Assessing smoking cessation services and pharmacotherapy in Namibia: findings and implications for future policy initiatives	2
Pattern of drug use in patients with psoriatic arthritis in Italy: study in a real-world setting	2
Leveraging the holistic benefits of biosimilars in Europe – part 2: how payers can safeguard the future of a healthy biosimilar market environment	2
Estimating cost-effectiveness of screening for colorectal cancer in Vietnam	2
Value assessment of new interventions for Alzheimer’s disease dementia in Japan based on literature review and group interview	2
Economic evaluation of rotavirus vaccination: an important step of the introduction to the national immunization program in Thailand	2
Willingness to pay for cancer prevention, screening, diagnosis, and treatment: a systematic review	2
Psychometric properties of the Polish version of SF-12v2 in the general population survey	2
A systematic review of pharmacoeconomic evaluations on oral diarylquinoline-based treatment for drug-resistant tuberculosis: from high to low burden countries	2
Comparing measurement properties of EQ-5D and SF-6D in East and South-East Asian populations: a scoping review	2
Cost-effectiveness of stereotactic body radiotherapy in the treatment of non–small-cell lung cancer (NSCLC): a systematic review	2
The role of insurance policies in the drug pricing landscape	2
Trastuzumab biosimilar HLX02 versus reference trastuzumab in patients with recurrent or metastatic HER2-positive breast cancer: a model-based economic evaluation for China	2
Disease and economic burden of surgery in desmoid tumors: a review	2
Economic analysis of cerliponase alfa for treatment of late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2)	2
Early economic evaluation of an intervention to improve uptake of the NHS England Diabetes Prevention Programme	2
Assessment of the quality and trend of reporting of health economic evaluation research in India	2
Economic burden of cervical cancer and premalignant lesions associated with human papilloma virus: a societal perspective	2
A latanoprost cationic emulsion (STN1013001) vs. other latanoprost formulations (Latanoprost) in open angle glaucoma/ocular hypertension and ocular surface disease: an Italian cost-utility analysis	2
Systematic review of the impact of health care expenditure on health outcome measures: implications for cost-effectiveness thresholds	2
Burden of illness of progressive familial intrahepatic cholestasis in the US, UK, France, and Germany: study rationale and protocol of the PICTURE study	2
Risk prediction algorithms in guiding antiviral therapy initiation among patients with chronic hepatitis B in Thailand: an economic evaluation and budget impact analysis	1
Assessing the economic impact of digital endpoints on medication adherence	1
Economic benefits of global Collaborative Health technology	1
Evaluating the correlations of cost and utility parameters from summary statistics for probabilistic analysis in economic evaluations	1
The economic value of knowing BRCA status: BRCA testing for optimizing treatment in recurrent epithelial ovarian cancer	1
Economic burden of highly active relapsing-remitting multiple sclerosis patients in the French national health insurance database	1
Cost considerations of dermatological care in Jordan: a cross-sectional study	1
Economic evaluation of plerixafor addition in the mobilization and leukapheresis of hematopoietic stem cells for autologous transplantation: a systematic review	1
Use of machine learning to predict bladder cancer survival outcomes: a systematic literature review	1
Cost-effectiveness analysis of atezolizumab plus chemotherapy as first-line treatment for patients with advanced nonsquamous non-small-cell lung cancer in China	1
Economic burden of depression in Brazil: a cost-of-illness study based on productivity losses and healthcare costs between 2010 to 2018	1
Consumption of antidepressants and economic austerity in Brazil	1
An early health technology assessment of 3D anatomic models in pediatric congenital heart surgery: potential cost-effectiveness and decision uncertainty	1
Cost-effectiveness and drug wastage of bevacizumab biosimilar with or without chemotherapy for platinum-resistant recurrent ovarian cancer	1
What are the difficulties of implementing innovative pharmacy practice models in the care of patients with dementia?	1
Engagement of medication users in the development and implementation of digital medication adherence technologies: a multi-stakeholder study	1
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents matter?	1
Direct medical and indirect absenteeism costs among working adult ADHD patients in the United States	1
Effects, trends, costs associated with readmission in early-aged patients with suicidal ideation	1
Cost-effectiveness evaluation of mirabegron versus anti-muscarinics and third-line therapies: a systematic review	1
Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC)	1
Effects of utilization management on health outcomes: evidence from urinary tract infections and community-acquired pneumonia	1
Seeing the whole elephant: integrated advanced data analytics in support of RWE for the development and use of innovative pharmaceuticals	1
What might have happened: the impact of interrupting entry of innovative drugs on disease outcomes in the United States	1
The budget impact of introducing the OMNI® surgical system to a United States health plan for managing mild-to-moderate primary open-angle glaucoma	1
Value-based performance arrangements for chronic conditions: an economic simulation of Medicaid Drug Rebate Program reforms	1
Description of characteristics, management of care and healthcare direct costs of patients with HR+/HER2- early breast cancer in Italy: a real-world study involving administrative and pathological ana	1
Canadian English translation and linguistic validation of the 13-MD to measure global health-related quality of life	1
Nonadherence to antiseizure medications: what have we learned and what can be done next?	1
Cost-effectiveness and drug wastage of immunotherapeutic agents for hematologic malignancies: a systematic review	1
A roadmap for applying machine learning when working with privacy-sensitive data: predicting non-response to treatment for eating disorders	1
Challenges and opportunities in measuring the pediatric quality of life: exemplified by research in pediatric gastroenterology	1
Analysis of the prevalence of ankylosing spondylitis and treatment patterns and drug utilization among affected patients: an Italian real-world study	1
Economic value of knowing BRCA status: BRCA testing for prostate cancer prevention and optimal treatment	1
Budget impact analysis of daratumumab for light-chain amyloidosis in Cyprus	1
Clinical and economic outcomes associated with intravenous albumin fluid use in the intensive care unit: a retrospective cohort study	1
Economic burden of type-2 diabetes in Peru: a cost-of-illness study valuing cost differences associated with the level of glycemic control	1
The impact of conventional cost-effectiveness analysis on pricing dynamics in the market of new medicines: a proposed countervailing approach	1
The cost-effectiveness of using rapid diagnostic tests for the diagnosis of typhoid fever in patients with suspected typhoid fever: a systematic review	1
A visual approach to the economic evaluation of vaccines: opening the health economic black box	1